Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$48.48 - $57.85 $16,289 - $19,437
-336 Reduced 5.49%
5,784 $296,000
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $984 - $1,100
-17 Reduced 0.28%
6,120 $355,000
Q2 2023

Jul 25, 2023

SELL
$63.71 - $70.74 $72,629 - $80,643
-1,140 Reduced 15.67%
6,137 $392,000
Q1 2023

May 04, 2023

SELL
$65.71 - $74.53 $22,998 - $26,085
-350 Reduced 4.59%
7,277 $504,000
Q4 2022

Feb 07, 2023

SELL
$68.48 - $81.09 $23,146 - $27,408
-338 Reduced 4.24%
7,627 $549,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $19 - $11,526
150 Added 1.92%
7,965 $566,000
Q2 2022

Aug 10, 2022

SELL
$72.62 - $79.98 $13,870 - $15,276
-191 Reduced 2.39%
7,815 $602,000
Q1 2022

Apr 08, 2022

SELL
$61.48 - $73.72 $6,148 - $7,372
-100 Reduced 1.23%
8,006 $585,000
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $19,843 - $23,132
-370 Reduced 4.37%
8,106 $506,000
Q3 2021

Nov 01, 2021

BUY
$59.17 - $69.31 $28,638 - $33,546
484 Added 6.06%
8,476 $502,000
Q1 2021

Apr 12, 2021

SELL
$59.34 - $66.74 $62,900 - $70,744
-1,060 Reduced 11.71%
7,992 $505,000
Q4 2020

Feb 17, 2021

SELL
$57.74 - $65.43 $129,279 - $146,497
-2,239 Reduced 19.83%
9,052 $562,000
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $44,048 - $48,811
-767 Reduced 6.36%
11,291 $681,000
Q2 2020

Aug 07, 2020

SELL
$54.82 - $64.09 $164,076 - $191,821
-2,993 Reduced 19.89%
12,058 $709,000
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $113,123 - $164,394
-2,438 Reduced 13.94%
15,051 $839,000
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $273,263 - $356,447
5,553 Added 46.52%
17,489 $1.12 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $41,529 - $49,239
971 Added 8.86%
11,936 $605,000
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $22,488 - $24,867
504 Added 4.82%
10,965 $497,000
Q1 2019

May 08, 2019

BUY
$45.12 - $53.8 $12,633 - $15,064
280 Added 2.75%
10,461 $499,000
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $6,095 - $7,903
-125 Reduced 1.21%
10,181 $529,000
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $6,126 - $6,909
111 Added 1.09%
10,306 $639,000
Q2 2018

Aug 01, 2018

BUY
$50.53 - $62.98 $21,626 - $26,955
428 Added 4.38%
10,195 $564,000
Q1 2018

May 17, 2018

SELL
$59.92 - $68.98 $26,244 - $30,213
-438 Reduced 4.29%
9,767 $618,000
Q4 2017

Feb 13, 2018

BUY
$59.94 - $65.35 $27,872 - $30,387
465 Added 4.77%
10,205 $626,000
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $537,940 - $620,827
9,740
9,740 $621,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Israel Discount Bank Of New York Portfolio

Follow Israel Discount Bank Of New York and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Israel Discount Bank Of New York, based on Form 13F filings with the SEC.

News

Stay updated on Israel Discount Bank Of New York with notifications on news.